William A Bauman1, Run Lin Zhang, Ann M Spungen. 1. Veterans Affairs Rehabilitation Research and Development Center of Excellence, James J. Peters Veterans Affairs Medical Center, Bronx, New York 10468, USA. william.bauman@med.va.gov
Abstract
BACKGROUND/ OBJECTIVE: A blunted growth hormone (GH) response to provocative testing and/or low levels of plasma insulin-like growth factor-I (IGF-I) have been reported in persons with spinal cord injury (SCI). A reduction in activity of the GH-IGF-I axis may have deleterious effects on body composition and function. Provocative testing for GH stimulation was performed to determine the response in monozygotic twins that were discordant for SCI. METHODS: GH stimulation testing was performed by the administration of intravenous arginine. RESULTS: Nine SCI twins with paraplegia, a mean age of 39 +/- 9 years, and duration of injury of 14 +/- 9 years were studied. The twins with SCI had a significantly lower body mass index than non-SCI twins (22.5 +/- 4.0 vs 25.1 +/- 4.2 kg/m2; P < 0.05); percent fat mass was greater in the twins with SCI (30 +/- 11% vs 22 +/- 10%; P < 0.05). Baseline serum GH was correlated with percent fat only in the SCI twins. The response to GH provocative stimulation was less in the twins with SCI: peak GH response was 5.8 +/- 6.6 vs 13.0 +/- 7.3 ng/mL (P < 0.05), and sum GH response was 15.7 +/- 15.6 vs 30.2 +/- 17.3 ng/mL (P = 0.06). Although baseline serum GH was correlated with stimulated response in the SCI twins, this relationship was not found in the non-SCI twins. Adiposity was positively related to the provocative serum GH response in twins with SCI rather than negatively related, as noted in the non-SCI twins. CONCLUSIONS: This study confirms and extends prior work that reported a reduction in stimulated GH release in persons with SCI, which was related to baseline values.
BACKGROUND/ OBJECTIVE: A blunted growth hormone (GH) response to provocative testing and/or low levels of plasma insulin-like growth factor-I (IGF-I) have been reported in persons with spinal cord injury (SCI). A reduction in activity of the GH-IGF-I axis may have deleterious effects on body composition and function. Provocative testing for GH stimulation was performed to determine the response in monozygotic twins that were discordant for SCI. METHODS:GH stimulation testing was performed by the administration of intravenous arginine. RESULTS: Nine SCI twins with paraplegia, a mean age of 39 +/- 9 years, and duration of injury of 14 +/- 9 years were studied. The twins with SCI had a significantly lower body mass index than non-SCI twins (22.5 +/- 4.0 vs 25.1 +/- 4.2 kg/m2; P < 0.05); percent fat mass was greater in the twins with SCI (30 +/- 11% vs 22 +/- 10%; P < 0.05). Baseline serum GH was correlated with percent fat only in the SCI twins. The response to GH provocative stimulation was less in the twins with SCI: peak GH response was 5.8 +/- 6.6 vs 13.0 +/- 7.3 ng/mL (P < 0.05), and sum GH response was 15.7 +/- 15.6 vs 30.2 +/- 17.3 ng/mL (P = 0.06). Although baseline serum GH was correlated with stimulated response in the SCI twins, this relationship was not found in the non-SCI twins. Adiposity was positively related to the provocative serum GH response in twins with SCI rather than negatively related, as noted in the non-SCI twins. CONCLUSIONS: This study confirms and extends prior work that reported a reduction in stimulated GH release in persons with SCI, which was related to baseline values.
Authors: William A Bauman; Ann M Spungen; Jack Wang; Richard N Pierson; Ernest Schwartz Journal: Am J Physiol Endocrinol Metab Date: 2006-01-17 Impact factor: 4.310
Authors: J O Jørgensen; S A Pedersen; L Thuesen; J Jørgensen; T Ingemann-Hansen; N E Skakkebaek; J S Christiansen Journal: Lancet Date: 1989-06-03 Impact factor: 79.321
Authors: Andrew R Hoffman; Christian J Strasburger; Anthony Zagar; Werner F Blum; Anne Kehely; Mark L Hartman Journal: J Clin Endocrinol Metab Date: 2004-07 Impact factor: 5.958
Authors: Ann M Spungen; Rodney H Adkins; Charles A Stewart; Jack Wang; Richard N Pierson; Robert L Waters; William A Bauman Journal: J Appl Physiol (1985) Date: 2003-08-08
Authors: Dafin F Muresanu; Aruna Sharma; José V Lafuente; Ranjana Patnaik; Z Ryan Tian; Fred Nyberg; Hari S Sharma Journal: Mol Neurobiol Date: 2015-07-01 Impact factor: 5.590
Authors: William A Bauman; Michael F La Fountaine; Christopher M Cirnigliaro; Steven C Kirshblum; Ann M Spungen Journal: J Spinal Cord Med Date: 2013-09 Impact factor: 1.985
Authors: Carlos G Martínez-Moreno; Denisse Calderón-Vallejo; Steve Harvey; Carlos Arámburo; José Luis Quintanar Journal: Int J Mol Sci Date: 2018-01-26 Impact factor: 5.923